Applications of Generative Adversarial Networks in Neuroimaging and Clinical Neuroscience

Abstract

Generative adversarial networks (GANs) are one powerful type of deep learning models that have been successfully utilized in numerous fields. They belong to a broader family called generative methods, which generate new data with a probabilistic model by learning sample distribution from real examples. In the clinical context, GANs have shown enhanced capabilities in capturing spatially complex, nonlinear, and potentially subtle disease effects compared to traditional generative methods. This review appraises the existing literature on the applications of GANs in imaging studies of various neurological conditions, including Alzheimer's disease, brain tumors, brain aging, and multiple sclerosis. We provide an intuitive explanation of various GAN methods for each application and further discuss the main challenges, open questions, and promising future directions of leveraging GANs in neuroimaging. We aim to bridge the gap between advanced deep learning methods and neurology research by highlighting how GANs can be leveraged to support clinical decision making and contribute to a better understanding of the structural and functional patterns of brain diseases.

References in corpus (4)

• GANs Trained by a Two Time-Scale Update Rule Converge to a Local Nash Equilibrium
• Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities and Results of the WMH Segmentation Challenge
• Statistical power and prediction accuracy in multisite resting-state fMRI connectivity
• Multimodal Functional and Structural Brain Connectivity Analysis in Autism: A Preliminary Integrated Approach with EEG, fMRI and DTI

Cited by in corpus (3)

• Data augmentation with automated machine learning: approaches and performance comparison with classical data augmentation methods
• Evaluation of pseudo-healthy image reconstruction for anomaly detection with deep generative models: Application to brain FDG PET
• Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience